Sachdev Amit

Average Profitability
5.21%
Insider Buys Quantity
1
Insider Buys Sum
$24,720.00
Insider Sells Quantity
103
Insider Sells Sum
$165.66M

Insider Activity of Sachdev Amit

According to the SEC Form 4 filings, Sachdev Amit, being in a position of

  1. EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 13738 shares for $5.8M,
    over all time since 2007-11-07, has bought 1000 shares for $24,720, and sold 1283024 shares for $165.66M.

The largest purchase of all time was on 2007-11-07 and amounted to 1000 shares of Vertex Pharmaceuticals Incorporated for $24,720.

The largest sale of all time was on 2014-09-30 and amounted to 172000 shares of Vertex Pharmaceuticals Incorporated for $19.38M.

Biography of Sachdev Amit

No biography is available at this moment.

2024-05-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
32
<0.0001%
$430.93$13,790+8.62%
2024-02-26SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
3,004
0.0011%
$425.70$1.28M+6.7%
2024-02-21SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
3,191
0.0012%
$421.77$1.35M+9.62%
2024-02-20SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
4,254
0.0016%
$420.79$1.79M+9.23%
2024-02-12SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
3,222
0.0013%
$420.24$1.35M+8.8%
2023-11-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
35
<0.0001%
$369.92$12,947+22.97%
2023-08-10SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
10,031
0.0039%
$350.00$3.51M+17.33%
2021-11-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
51
<0.0001%
$187.19$9,547+44.25%
2021-05-17SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
45
<0.0001%
$216.35$9,736-4.41%
2021-04-27SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
3,884
0.0015%
$216.06$839,193-4.05%
2021-02-25SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
3,586
0.0014%
$213.42$765,307-2.9%
2021-02-18SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
9,264
0.0036%
$211.83$1.96M-1.39%
2021-02-11SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
4,460
0.0017%
$210.55$939,068-1.76%
2020-11-16SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
42
<0.0001%
$223.53$9,388-6.17%
2020-08-03SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
1,941
0.0007%
$278.28$540,137-22.49%
2020-05-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
58
<0.0001%
$284.41$16,496-19.72%
2020-05-11SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
10,665
0.0041%
$282.61$3.01M-18.47%
2020-05-06SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
669
0.0003%
$275.28$184,162-13.36%
2020-05-05SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
13,356
0.0051%
$270.01$3.61M-13.89%
2020-05-04SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
43,752
0.0167%
$262.28$11.48M-11.37%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.